L&K Biomed India Private Limited
Manufactures and trades medical equipment and machinery, established in 2017.
2017 | Gurugram, Haryana (India) | Active
L&K Biomed India Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 6.95 M
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 35.65%
- Net Worth -72.78%
- Total Assets 689.97%
About L&K Biomed India
L&K Biomed India Private Limited (LBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 November 2017 (Seven years and three months 23 days old ). Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 6.95 M, as per Ministry of Corporate Affairs (MCA) records.
Puneet Kapoor and Guk Kang serve as directors at the Company.
Company Details
- Location
Gurugram, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999HR2017PTC088868
- Company No.
325632
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Nov 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Healthcare
Who are the key members and board of directors at L&K Biomed India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Puneet Kapoor  | Director | 06-Nov-2017 | Current |
Guk Kang  | Additional Director | 26-Jul-2022 | Current |
Financial Performance of L&K Biomed India.
L&K Biomed India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 35.65% increase in profit. The company's net worth observed a substantial decline by a decrease of 72.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of L&K Biomed India?
Unlock access to L&K Biomed India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at L&K Biomed India?
Unlock and access historical data on people associated with L&K Biomed India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of L&K Biomed India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped L&K Biomed India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
